Literature DB >> 17600129

Molecular changes in the vasculature of injured tissues.

Tero A H Järvinen1, Erkki Ruoslahti.   

Abstract

We have explored molecular specialization of the vasculature of regenerating wound tissue in the skin and tendons to identify a different repertoire of markers from that obtained by studying tumor vasculature. We screened a phage-displayed peptide library for peptides that home to wounds in mice and identified two peptides that selectively target phage to skin and tendon wounds: CARSKNKDC (CAR) and CRKDKC (CRK). CAR is homologous to heparin-binding sites in various proteins and binds to cell surface heparan sulfate and heparin. CRK is similar to a segment in thrombospondin type 1 repeat. Intravenously injected CAR and CRK phage, as well as fluorescein-labeled CAR and CRK peptides, selectively accumulated at wound sites, where they partially co-localized with blood vessels. The CAR peptide showed a preference for early stages of wound healing, whereas the CRK favored wounds at later stages of healing. The CAR peptide was internalized into the target cells and delivered the fluorescent label into the cell nuclei. These results identify new molecular markers in wound tissues and show that the expression of these markers in wound vasculature changes as healing progresses. The peptides recognizing these markers may be useful in delivering treatments into regenerating tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600129      PMCID: PMC1934529          DOI: 10.2353/ajpath.2007.061251

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium.

Authors:  Amr El-Sheikh; Cheng Liu; Haining Huang; Thomas S Edgington
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Matrix reloaded to circulation hits the tumor target.

Authors:  Sara A Wickström; Jorma Keski-Oja; Kari Alitalo
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

3.  Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.

Authors:  Johanna A Joyce; Pirjo Laakkonen; Michele Bernasconi; Gabriele Bergers; Erkki Ruoslahti; Douglas Hanahan
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

4.  Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.

Authors:  Jason A Hoffman; Enrico Giraudo; Mallika Singh; Lianglin Zhang; Masahiro Inoue; Kimmo Porkka; Douglas Hanahan; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

5.  In vivo interrogation of the molecular display of atherosclerotic lesion surfaces.

Authors:  Cheng Liu; Gourab Bhattacharjee; William Boisvert; Ralph Dilley; Thomas Edgington
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

6.  A tumor-homing peptide with a targeting specificity related to lymphatic vessels.

Authors:  Pirjo Laakkonen; Kimmo Porkka; Jason A Hoffman; Erkki Ruoslahti
Journal:  Nat Med       Date:  2002-06-10       Impact factor: 53.440

Review 7.  Specialization of tumour vasculature.

Authors:  Erkki Ruoslahti
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

8.  Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels.

Authors:  Sven Christian; Jan Pilch; Maria E Akerman; Kimmo Porkka; Pirjo Laakkonen; Erkki Ruoslahti
Journal:  J Cell Biol       Date:  2003-11-24       Impact factor: 10.539

Review 9.  Interactions between heparan sulfate and proteins: the concept of specificity.

Authors:  Johan Kreuger; Dorothe Spillmann; Jin-ping Li; Ulf Lindahl
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

10.  Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature.

Authors:  D M Gerlag; E Borges; P P Tak; H M Ellerby; D E Bredesen; R Pasqualini; E Ruoslahti; G S Firestein
Journal:  Arthritis Res       Date:  2001-09-06
View more
  35 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

3.  A novel vascular homing peptide strategy to selectively enhance pulmonary drug efficacy in pulmonary arterial hypertension.

Authors:  Michie Toba; Abdallah Alzoubi; Kealan O'Neill; Kohtaro Abe; Takeo Urakami; Masanobu Komatsu; Diego Alvarez; Tero A H Järvinen; David Mann; Erkki Ruoslahti; Ivan F McMurtry; Masahiko Oka
Journal:  Am J Pathol       Date:  2014-01-06       Impact factor: 4.307

Review 4.  Generation of a multi-functional, target organ-specific, anti-fibrotic molecule by molecular engineering of the extracellular matrix protein, decorin.

Authors:  Tero A H Järvinen; Erkki Ruoslahti
Journal:  Br J Pharmacol       Date:  2018-06-25       Impact factor: 8.739

5.  CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil.

Authors:  Ali Keshavarz; Ahmed Alobaida; Ivan F McMurtry; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2019-06-27       Impact factor: 4.939

6.  Pulmonary Targeting of Adeno-associated Viral Vectors by Next-generation Sequencing-guided Screening of Random Capsid Displayed Peptide Libraries.

Authors:  Jakob Körbelin; Timo Sieber; Stefan Michelfelder; Lars Lunding; Elmar Spies; Agnes Hunger; Malik Alawi; Kleopatra Rapti; Daniela Indenbirken; Oliver J Müller; Renata Pasqualini; Wadih Arap; Jürgen A Kleinschmidt; Martin Trepel
Journal:  Mol Ther       Date:  2016-03-28       Impact factor: 11.454

7.  Nanoparticle-induced vascular blockade in human prostate cancer.

Authors:  Lilach Agemy; Kazuki N Sugahara; Venkata Ramana Kotamraju; Kunal Gujraty; Olivier M Girard; Yuko Kono; Robert F Mattrey; Ji-Ho Park; Michael J Sailor; Ana I Jimenez; Carlos Cativiela; David Zanuy; Francisco J Sayago; Carlos Aleman; Ruth Nussinov; Erkki Ruoslahti
Journal:  Blood       Date:  2010-06-29       Impact factor: 22.113

8.  Dynamic Regulation of Integrin α6β4 During Angiogenesis: Potential Implications for Pathogenic Wound Healing.

Authors:  Diana Desai; Purva Singh; Livingston Van De Water; Susan E Laflamme
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-10       Impact factor: 4.730

Review 9.  Bacteriophage-based biomaterials for tissue regeneration.

Authors:  Binrui Cao; Yan Li; Tao Yang; Qing Bao; Mingying Yang; Chuanbin Mao
Journal:  Adv Drug Deliv Rev       Date:  2018-11-16       Impact factor: 15.470

Review 10.  Targeting of drugs and nanoparticles to tumors.

Authors:  Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  J Cell Biol       Date:  2010-03-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.